Chemotherapy Side Effects
Chemotherapy Side Effects 2
Immunotherapy Side Effects
Immunotherapy Side Effects 2
Supportive Care Side Effects
Labs/Diagnostic Testing
Calculations
Oncologic Emergencies
100

Carboplatin

Neutropenia; thrombocytopenia; nausea; vomiting; hypersensitivity; alopecia; rash

100

Oxaliplatin

Peripheral neuropathy; myelosuppression; anaphylactic reactions; nausea; vomiting; diarrhea; pulmonary fibrosis; fatigue; fever; increased transaminases; increased alkaline phosphatase

100

Nivolumab

Fatigue; malaise; peripheral neuropathy; GI toxicities; elevated LFTs; increased creatinine; electrolyte imbalances; weakness; anemia; neutropenia; thrombocytopenia; myalgia; upper respiratory tract infection; cough; febrile reaction; immune-mediated adverse reactions

100

Pembrolizumab

Fatigue; rash; hyperglycemia; metabolic imbalances; GI toxicities; vomiting; urinary tract infection; anemia; lymphocytopenia; thrombocytopenia; elevated LFTs; increased serum creatinine; fever; immune-mediated adverse reactions

100

Ferric carboxymaltose

Nausea; vomiting; changes in taste; headache; injection site reactions; brown discoloration of the skin; hot flashes/flushing

100

Zoledronic Acid

Serum creatinine

100

BSA (DuBois)

Male, 205 lbs, 74 inches tall

2.2

100

Sepsis

Risk: Cancer; > 60 years old, prolonged neutropenia (> 7 days), implanted catheter

Symptoms: Fever; mental status changes; confusion; difficulty arousing; severe pain/discomfort; hypotension; tachycardia; tachypnea

Interventions: antimicrobials, hemodynamic support, fluid resuscitation, vasopressors, oxygen

200

Cyclophosphamide

Hemorrhagic cystitis; myelosuppression; nausea; vomiting; alopecia; maxillary burning; acute cardiomyopathy; SIADH

200

Fluorouracil

Mucositis; myelosuppression; nausea; anorexia; vomiting; diarrhea; alopecia; ocular toxicities; darkening of the veins; dry skin; neurotoxicity; palmar-plantar erythrodysesthesia

200

Atezolizumab

Fatigue; hypoalbuminemia; hyponatremia; decreased appetite; nausea; constipation; increased serum alkaline phosphatase; increased serum AST and ALT; antibody development; infection; musculoskeletal pain; fever; immune-mediated adverse reactions

200

Pertuzumab

Black box: left ventricular dysfunction, embryo-fetal toxicity; weakness; myalgias; neutropenia; anemia; diarrhea; nausea; vomiting; alopecia; rash; fatigue; headache; cardiac dysfunction

200

Denosumab

Osteonecrosis of the jaw; hypocalcemia; hypophosphatemia; dyspnea; injection-site reactions

200

Carboplatin

Serum creatinine

200

BSA (DuBois)

Female, 145 lbs, 63 inches tall

1.69

200

Immune effector cell-associated neurotoxicity syndrome (ICANS)

Neurotoxicity associated with CAR T-cell; bispecific T cell engager therapies. 

Risk: CRS; pre-existing neuro comorbidities; younger age; high disease burden; ALL; pre-treat elevated LDH, decreased platelet, high ferritin day 3 post admin

Assessment: ICE assessment (handwriting, counting backwards, object identification, orientation to time/space etc)

300

Gemcitabine

Myelosuppression; thrombocytopenia; nausea; vomiting; fever; headache; arthralgias; myalgias; rash; peripheral edema; dyspnea; pulmonary toxicity; hepatoxicity

300
Doxorubicin
Myelosuppression; cardiotoxicity; hepatotoxicity; nausea; vomiting; alopecia; mucositis; radiation recall; hyperuricemia; photosensitivity; red-colored urine
300

Rituximab

Black box: infusion-related reactions within 24 hours, TLS; fatigue; chills; neuropathy; nausea; lymphocytopenia; anemia; infection; weakness

300

Cemiplimab-rwlc

Fatigue; rash; diarrhea; pneumonitis; colitis; hepatitis; endocrinopathies; nephritis; dermatologic toxicities

300

Darbepoetin alfa

Shortness of breath, cough, abdominal pain, edema, hypertension, rash, urticaria, myalgia, infection, fatigue, diarrhea, thrombotic events

300
Denosumab

Calcium Levels

300

BSA (DuBois):

Male, 175 lbs, 68 inches tall

1.93

300

Cytokine Release Syndrome

Symptoms: myalgias; headache; fever; fatigue; nausea; hypotension; capillary leak

Treatment: Corticosteroids, Tocilizumab; symptom management

Timing: Within 14 days

400

Etoposide

Myelosuppression; hypersensitivity reaction; nausea; vomiting; alopecia; anorexia; hypotension

400

Azacitidine

Myelosuppression; elevated serum creatinine; nausea; vomiting; diarrhea; fatigue; fever; erythema at the injection site; constipation
400

Ado-trastuzumab emtansine

Fatigue; nausea; musculoskeletal pain; arthralgia; peripheral neuropathy; headache; increased transaminases; constipation; thrombocytopenia; bleeding; epistaxis; cardiotoxicity

400

Fam-trastuzumab deruxtecan

Pneumonitis; cough; dyspnea; fever; worsening respiratory status; nausea; fatigue; vomiting; alopecia; constipation; decreased appetite; anemia; diarrhea; leukopenia; thrombocytopenia; left ventricular dysfunction

400

Filgrastim

Urticaria, rash, facial edema, acute respiratory distress syndrome, nausea, vomiting, bone pain, fever, risk of splenic rupture
400

Filgrastim

Neutrophils

400

ANC calculation:

WBC = 1.2; % Neutrophils = 70; % Lymphocytes = 31; % Monocytes = 9; % Bands = 3

876

400

Tumor Lysis Syndrome

When large numbers of rapidly dividing cells are killed and release their contents into the bloodstream

Risk: high tumor burden/bulky tumors; leukemias, lymphomas, some solid tumors; poor renal function

Symptoms: elevated uric acid, phosphorus, potassium, BUN, and/or creatinine; decreased calcium; oliguria, anuria, flank pain, dysrhythmias, n/v/d, anorexia, cramps, confusion

Prevention: allopurinol, rasburicase

500

Bleomycin

Hypersensitivity; pulmonary toxicity; hyperpigmentation; alopecia; photosensitivity; renal toxicity; hepatotoxicity; fever; chills; erythema; rash; mucositis

500

Paclitaxel protein-bound

Myelosuppression; sensory neuropathy; sepsis; pneumonitis; hypersensitivity reaction; alopecia; anemia; myalgia/arthralgia; nausea; vomiting; diarrhea

500

Cetuximab

Black box: cardiopulmonary arrest, infusion-related reactions; fatigue; pain; peripheral neuropathy; headache; insomnia; weight loss; skin toxicities; hypomagnesemia; dehydration; GI toxicities; elevated LFTs; weakness; dyspnea; cough; fever; pharyngitis
500

Daratumumab

Fatigue; nausea; lymphocytopenia; neutropenia; anemia; back pain; cough; fever; infusion-related reactions; asthenia; diarrhea; constipation; decreased appetite; vomiting; muscle spasms; arthralgia; fever; chills; dizziness; insomnia; cough; dyspnea; peripheral edema; peripheral neuropathy; bronchitis; pneumonia; upper respiratory tract infection

500

Pegfilgrastim

Urticaria, rash, facial edema, acute respiratory distress syndrome, nausea, vomiting, bone pain, fever, risk of splenic rupture

500

Atezolizumab

LFTs

500

Carboplatin calculation: 

Male, 65 years old, 5'10", 200 lbs, serum creatinine 1.0. Target AUC = 6

718 mg

500

Superior Vena Cava Syndrome

Risks: lung ca or non-Hodgkin lymphoma

Symptoms: facial swelling; head fullness; facial/chest/neck/upper-extremity edema; dyspnea; nonproductive cough; distended chest veins

Assess: respiratory, cardiovascular, neurologic compromise; supportive care (oxygen, bronchodilators, elevate head, anxiety mgmt)

600

Vinorelbine

Myelosuppression; hepatotoxicity; severe constipation and bowel obstruction; neurotoxicity; peripheral neuropathy; pulmonary toxicity; respiratory failure; nausea; vomiting; alopecia

600

Arsenic trioxide

Fatigue; prolonged QT interval; leukocytosis; headache; nausea; vomiting; diarrhea; abdominal pain; fever; dermatitis; cough; dyspnea; peripheral neuropathy

600

Eculizumab

Headache; nasopharyngitis; back pain; nausea; increased risk of meningococcal infections; infusion-related reactions

600

Brentuximab vedotin

Peripheral neuropathy; fatigue; rash; neutropenia; anemia; upper respiratory tract infection; cough; fever; infusion-related reactions; nausea; constipation; vomiting; alopecia; decreased weight; abdominal pain; stomatitis; thrombocytopenia; lymphopenia; mucositis; renal toxicity; hepatotoxicity

600

IVIG

Headache, chills, fever, flushing, muscle pain, joint pain, fatigue, nausea, vomiting, rash

600

Trastuzumab

Echocardiogram

600

Carboplatin Calculation:

Female, 50 years old, 5'5", 185 lbs, serum creatinine 0.8. Target AUC= 5

685 mg

600

Disseminated Intravascular Coagulation

What it is: clotting and bleeding occur simultaneously

Risk factors: APL; adenocarcinomas; CAR-T

Symptoms: oozing to uncontrolled hemorrhage; s/s of internal bleeding; ischemia; infarction; organ failure

Assess for s/s of bleeding or thrombosis; monitor labs, vital signs, oxygenation and fluid status